Pfizer shares experienced a healthy 7.71% gain today as the company announced a patent victory on its biggest selling drug. This stock is technically interesting because it gapped up toward the combined resistance of the October highs and the 200 DMA. These levels have prevented the bulls from pushing the price higher on several previous occasions, and we believe that this may be the case again.


You May Also Like

Related Analysis
  1. Investing News

    Europe's Oil Refineries Get A Second Chance

  2. Chart Advisor

    Watch For These Chart Pattern Breakouts Right Now

  3. Stock Analysis

    SALT 2015: A Global Macroeconomic Forecast Hosted By Steve Forbes

  4. Stock Analysis

    Orexigen Earnings Preview: 5 Things to Look For

  5. Stock Analysis

    3 Key Takeaways From Chesapeake Energy's Earnings

Trading Center